The overall lobectomy rate for benign disease in the VIOLET trial was 1.4%. This is even though nearly half of the participants went to the OR without a histopathological confirmation of lung cancer. Eric Lim lungcancerjournal.info/article/S0169-…

Thank you Professor Pan-Chyr Yang for an excellent presentation today on Screening for Non-Smoking Lung Cancer! Watch the full session⬇️ Listen on Spotify: open.spotify.com/episode/0crSss… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Join us Friday (28 Feb) at 8am GMT, for a session with Dr Laurens Ceulemans (Laurens Ceulemans), Thoracic and Lung Transplant Surgeon University Hospitals Leuven. 🩺 Topic: Update on Lung Volume Reduction Surgery 📅 Don’t miss out—register below! ⬇️ Eric Lim AstraZeneca Medtronic

Thank you to Professor Laurens Ceulemans (Laurens Ceulemans) for today's excellent presentation on Update on Lung Volume Reduction Surgery! Full session below⬇️ Listen on Spotify: open.spotify.com/episode/7bjCMT… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Join us Friday (14 Mar) at 8am GMT for a session with Professor Anna Nowak (Anna Nowak), Deputy Vice Chancellor (Research) at the University of Western Australia. 💡 Topic: TNM9 Staging for Mesothelioma Don’t miss out—register below! ⬇️ Eric Lim AstraZeneca Medtronic

Thank you to Professor Anna Nowak (Anna Nowak) for today's excellent presentation on TNM9 Staging for Mesothelioma! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/7kE0A4… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Join us on Friday (21 Mar) at 8am GMT for an exciting session with Professor Andrew Nicholson, Consultant Histopathologist at Royal Brompton Hospital. 💡 Topic: Update on Diagnosis of Mesothelioma Don’t miss out—register below! ⬇️ Eric Lim AstraZeneca Medtronic

Thank you to Professor Andrew Nicholson for today's excellent presentation on Update on Diagnosis of Mesothelioma! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/4vmHMD… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Interesting reflections and thoughts coming from ⁦Eric Lim⁩ PI in MARS2 trial about the impact and limits of surgery in Malignant Pleural Mesothelioma at #ELCC2025. Example of rigorous analysis ⁦ESMO - Eur. Oncology⁩ ⁦OncoAlert⁩

Thank you to Professor Anne-Marie Dingemans for today's excellent presentation on Antibody-Drug Conjugates for Lung Cancer! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/6yvHo2… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Join us on Friday (11 April) at 8 am BST for an exciting session with Prof. Justin Gainor, Director of Center for Thoracic Cancers Program at Mass General Cancer Center. 💡 Topic: New Targeted Treatments for Lung Cancer (HER2, RET) Register below! ⬇️ Eric Lim AstraZeneca Medtronic

Thank you to Dr Justin Gainor for today's excellent presentation on New Targeted Treatments for Lung Cancer (HER2, RET)! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/1o69TI… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Don't forget to join us tomorrow at 8 am BST for a session with Dr Martin Forster, Associate Professor & Consultant Medical Oncologist at UCL. 💡Topic: Cell-Based Therapies for Lung Cancer Register here: drericlim.com/brompton-grand… Live attendees earn 1 CME point!

Join us on Friday (09 May) at 8 am BST for a session with Dr d.planchard, Thoracic Oncologist and Head of the Thoracic Pathology Committee at Gustave Roussy. 💡Topic: Multi-Modality Targeted Regimens for Lung Cancer Eric Lim AstraZeneca Medtronic

Thank you to Dr d.planchard for today's excellent presentation on Multi-Modality Targeted Regimens for Lung Cancer! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/7E5AW1… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

💠 Congreso #SECT2025 Randomised trials report higher risk of death with cyto-reductive surgery for mesothelioma. No matter how bad you think the trials are conducted, it's not going to change from harm to benefit. Accept it or conduct randomised trials to re-evaluate.

Join us on Friday (23 May) at 8am BST for a session with Dr Alan Sihoe, Cardio-Thoracic Surgeon at CUHK Medicine, and International Director of the Society of Thoracic Surgeons. 💡Topic: Uniportal Lung Resection After Neo-Adjuvant Treatment Eric Lim AstraZeneca Medtronic

Thank you to Dr Alan Sihoe for today's excellent presentation on Uniportal Lung Resection After Neo-Adjuvant Treatment! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/1dLrNe… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic

Join us on Friday (6 June) at 8am BST for a session with Professor Konrad Hoetzenecker, Professor of Surgery in the Department of Thoracic Surgery and Surgical Director of the Vanderbilt Lung Transplant Program. 💡Topic: Management of Tracheal Tumours Eric Lim AstraZeneca Medtronic

Thank you to Prof. Konrad Hoetzenecker for today's excellent presentation on Management of Tracheal Tumours! Watch the full session below ⬇️ Listen on Spotify: open.spotify.com/episode/2Tsrdu… Subscribe on Spotify: creators.spotify.com/pod/show/virtu… Eric Lim AstraZeneca Medtronic